These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In vitro immunity of rat peritoneal macrophages to Candida albicans. Joshi KR; Joshi H Indian J Chest Dis Allied Sci; 2000; 42(4):341-4. PubMed ID: 15597683 [TBL] [Abstract][Full Text] [Related]
25. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053 [TBL] [Abstract][Full Text] [Related]
31. [Itraconazole treatment in the suspension of pathological fungal colonization of the airway in patients with pulmonary tuberculosis]. Lovacheva OV; Kornienko II; Kul'ko AB; Slogotskaia LV; Litvinov VI Probl Tuberk Bolezn Legk; 2008; (1):42-6. PubMed ID: 18320659 [No Abstract] [Full Text] [Related]
32. [Candida infections in immunocompromised hosts]. Wasak-Szulkowska E Pol Merkur Lekarski; 2005 Jul; 19(109):5-9. PubMed ID: 16194017 [TBL] [Abstract][Full Text] [Related]
33. Candida albicans osteomyelitis in a diabetic foot ulcer. Yener S; Topcu A; Manisali M; Comlekci A; Yesil S J Diabetes Complications; 2009; 23(2):137-8. PubMed ID: 18413156 [No Abstract] [Full Text] [Related]
34. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. Ghannoum MA; Kim HG; Long L J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032 [TBL] [Abstract][Full Text] [Related]
35. Fungal infections in hematological neoplastic disease: the possibility of chemoprophylaxis. Fanci R; Campisi E; Faggi E; Rossi Ferrini PL; Gargani G Chemioterapia; 1984 Oct; 3(5):310-5. PubMed ID: 6398126 [TBL] [Abstract][Full Text] [Related]
36. Successful treatment of systemic candidiasis following cardiac surgery. Kozinn PJ; Lynfield J; Seelig MS Am J Dis Child; 1974 Jul; 128(1):106-8. PubMed ID: 4600639 [No Abstract] [Full Text] [Related]
37. Emergence of Candida albicans fungemia during voriconazole therapy. Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209 [No Abstract] [Full Text] [Related]
38. [Chicken macrophages as carrier cells for immunofluorescence with soluble cytoplasmic protein of C. albicans (author's transl)]. Rossi G; Augenstein A Mykosen; 1981 Oct; 24(10):604-10. PubMed ID: 7027038 [No Abstract] [Full Text] [Related]
39. Human fungal pathogen Candida albicans in the postgenomic era: an overview. Kabir MA; Hussain MA Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061 [TBL] [Abstract][Full Text] [Related]
40. Antifungal susceptibility of non-albicans Candida species causing fingernail onychomycosis. Upton A; Rogers K; Wood N; Morris AJ N Z Med J; 2004 Sep; 117(1201):U1060. PubMed ID: 15476017 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]